Dengue Fever: The Complete Clinical Guide

(Note: For PDF File Swipe To The End Of Article)

Introduction

Dengue fever is an acute viral infection transmitted primarily by infected Aedes mosquitoes. It is one of the most important mosquito-borne viral diseases in tropical and subtropical regions, where warm temperatures, rainfall, urbanization, population density, and inadequate mosquito-control measures allow transmission to continue. Dengue can affect people of all ages, and infection may range from a mild febrile illness to severe dengue with plasma leakage, shock, severe bleeding, and organ dysfunction.

The clinical course of dengue is particularly important because a patient who initially appears stable may deteriorate rapidly around the time the fever subsides. For this reason, understanding the phases of illness, warning signs, laboratory abnormalities, fluid management, and indications for hospitalization is essential for medical students and healthcare professionals.

Dengue is caused by four established antigenically distinct serotypes of dengue virus: DENV-1, DENV-2, DENV-3, and DENV-4. A person can be infected more than once because immunity following infection is primarily serotype-specific. A second infection with a different serotype can, in some circumstances, increase the risk of severe disease because of complex immune mechanisms.

Most symptomatic infections produce high fever accompanied by headache, retro-orbital pain, muscle and joint pain, nausea, vomiting, rash, and weakness. However, the severity of illness varies considerably. Some patients recover without complications, whereas others develop significant capillary leakage, thrombocytopenia, hemorrhage, hepatic involvement, neurological manifestations, or shock.

Dengue therefore should not be viewed simply as a febrile viral illness. Its management requires continuous clinical assessment, appropriate laboratory investigation, careful evaluation of hydration and circulation, recognition of warning signs, and timely intervention when severe disease develops.

Causative Organism

Dengue fever is caused by the dengue virus, a single-stranded positive-sense RNA virus belonging to the genus Flavivirus within the family Flaviviridae. The virus is closely related to other medically important flaviviruses, including yellow fever virus, West Nile virus, Japanese encephalitis virus, and Zika virus.

There are four major dengue virus serotypes:

• DENV-1
• DENV-2
• DENV-3
• DENV-4

All four serotypes can cause dengue fever and severe dengue. Infection with one serotype generally produces long-lasting immunity against that same serotype, but protection against the other serotypes is incomplete and temporary.

The dengue virion contains structural proteins that participate in viral entry and formation of the virus and non-structural proteins that are important for viral replication and interaction with the host immune system. Among these, the envelope protein is particularly important because it participates in attachment and entry into host cells and is an important target of the immune response.

The clinical severity of dengue is not determined solely by the viral serotype. Host factors, previous dengue infection, age, pregnancy, underlying diseases, immune responses, and the timing of clinical care can all influence the outcome.

Vector and Mode of Transmission

Dengue is primarily transmitted through the bite of infected female Aedes mosquitoes. The principal vector is Aedes aegypti, while Aedes albopictus can also transmit the virus.

Aedes aegypti is particularly well adapted to urban environments. It commonly breeds in artificial containers holding relatively small amounts of stagnant water. Examples include uncovered water-storage containers, discarded tires, buckets, flowerpots, roof gutters, bottles, and other objects capable of collecting rainwater.

The mosquito becomes infected when it feeds on a person whose blood contains dengue virus. After the virus undergoes replication inside the mosquito and reaches its salivary glands, the mosquito can transmit the infection to another person during a subsequent blood meal.

The mosquito is therefore an essential link between infected and susceptible individuals. Dengue is not normally spread through casual person-to-person contact such as touching, coughing, or sharing food.

Transmission can be influenced by environmental conditions. Warm temperatures can accelerate mosquito development and viral replication, while rainfall can increase the number of suitable breeding sites. Rapid urbanization, inadequate water management, poor waste disposal, and high population density can further facilitate transmission.

Although mosquito transmission is the dominant route, dengue virus can rarely be transmitted through other mechanisms, including transfusion of infected blood products, organ transplantation, and transmission from a pregnant person to the fetus or newborn.

Epidemiology and Global Importance

Dengue has become an increasingly important global public-health problem. It is endemic in many tropical and subtropical regions, particularly across South and Southeast Asia, Latin America, the Caribbean, parts of Africa, and the Pacific.

The geographic distribution of dengue is strongly influenced by the distribution of competent Aedes mosquito vectors. Increasing urbanization and international travel have also contributed to the expansion of dengue transmission into areas where the virus was previously uncommon.

Large outbreaks can place substantial pressure on healthcare systems because many patients may present simultaneously with fever, dehydration, thrombocytopenia, or warning signs requiring observation and fluid management.

Dengue is particularly important in countries where healthcare facilities may become overwhelmed during seasonal outbreaks. Early recognition and appropriate outpatient management can reduce unnecessary hospitalization, while timely identification of severe dengue can prevent avoidable deaths.

Pathophysiology

The pathophysiology of dengue is complex and involves interactions between the virus, immune system, vascular endothelium, blood cells, and multiple organs.

Following the bite of an infected mosquito, dengue virus enters the host and begins replicating in susceptible cells. Viral replication stimulates innate and adaptive immune responses. Cytokines, chemokines, complement activation, antibodies, and cellular immune responses contribute to the clinical manifestations of infection.

One of the most important pathological processes in severe dengue is increased vascular permeability. The endothelial barrier becomes functionally disrupted, allowing plasma to move from the intravascular compartment into surrounding tissues and body cavities.

This plasma leakage can result in:

• Hemoconcentration
• Pleural effusion
• Ascites
• Reduced circulating blood volume
• Hypotension
• Shock
• Tissue hypoperfusion

Importantly, the major problem in severe dengue is often plasma leakage rather than massive blood loss.

Thrombocytopenia is another characteristic laboratory abnormality. Reduced platelet counts may result from decreased platelet production, increased destruction, immune-mediated mechanisms, and consumption. Platelet dysfunction can also contribute to bleeding manifestations.

Dengue can additionally affect the liver, kidneys, heart, brain, lungs, and other organs. Severe disease may therefore involve multiple organ systems simultaneously.

Antibody-Dependent Enhancement

A particularly important immunological concept in dengue is antibody-dependent enhancement, commonly abbreviated as ADE.

After infection with one dengue serotype, the immune system produces antibodies that provide strong protection against that serotype. However, during a subsequent infection with a different serotype, some pre-existing antibodies may bind to the new virus without completely neutralizing it.

These antibody-virus complexes can interact with Fc-receptor-bearing immune cells and facilitate viral entry into certain cells. This mechanism may increase viral replication and contribute to an exaggerated immune response.

ADE is one proposed explanation for why secondary infection with a different serotype can be associated with increased risk of severe dengue. However, disease severity is multifactorial and cannot be explained by ADE alone.

Clinical Phases of Dengue

Dengue illness is commonly described in three clinical phases:

1. Febrile phase
2. Critical phase
3. Recovery phase

Recognizing these phases is clinically important because the patient's risk profile can change substantially even when the fever appears to be improving.

Febrile Phase

The febrile phase usually begins abruptly and is characterized by high fever. Fever may be accompanied by headache, retro-orbital pain, myalgia, arthralgia, nausea, vomiting, weakness, and sometimes a skin rash.

The fever commonly lasts several days. During this period, the patient may appear clinically stable despite significant systemic inflammation.

Laboratory testing may demonstrate leukopenia and a progressive reduction in platelet count.

A key clinical mistake is to assume that improvement in fever automatically means the patient is recovering. In dengue, the period around defervescence can coincide with the beginning of the critical phase.

Critical Phase

The critical phase generally occurs around the time the fever settles, often during the period when plasma leakage begins in patients who develop severe disease.

This phase is usually relatively short but can be dangerous. Increased vascular permeability may cause plasma to leave the circulation, leading to hemoconcentration and reduced effective circulating volume.

Warning signs may become evident during this period.

Patients can develop:

• Severe abdominal pain
• Persistent vomiting
• Clinical fluid accumulation
• Mucosal bleeding
• Lethargy or restlessness
• Liver enlargement
• Rising hematocrit with rapidly falling platelet count

If plasma leakage becomes severe, the patient can progress to dengue shock syndrome.

Recovery Phase

If plasma leakage resolves and circulation is restored, the patient enters the recovery phase. Extravasated fluid is gradually reabsorbed into the intravascular space.

The patient's appetite and general condition usually improve. Urine output increases, hemodynamic status stabilizes, and platelet counts begin to recover.

During this phase, excessive intravenous fluid administration can become dangerous because the vascular permeability is improving and previously leaked fluid is returning to the circulation. Therefore, fluid therapy must be reassessed carefully.

Clinical Features and Symptoms

Dengue may present with a broad spectrum of symptoms.

The classical clinical picture includes sudden-onset fever associated with headache, retro-orbital pain, muscle pain, joint pain, nausea, vomiting, weakness, and rash.

Fever

High-grade fever is one of the most common manifestations. It may be accompanied by chills, sweating, malaise, and marked fatigue.

The duration and pattern of fever alone cannot determine disease severity.

Headache

Headache is common and may be intense. It is frequently accompanied by pain behind the eyes.

Retro-Orbital Pain

Pain behind or around the eyes is a characteristic symptom and may become more noticeable with eye movement.

Myalgia and Arthralgia

Severe muscle and joint pain can occur, contributing to the historical description of dengue as "breakbone fever."

Nausea and Vomiting

Gastrointestinal symptoms are common. Persistent vomiting, however, is clinically important because it can contribute to dehydration and is also considered a warning sign.

Skin Rash

A maculopapular or diffuse rash may appear during the course of illness. The rash can vary considerably between patients.

Weakness and Fatigue

Profound fatigue may persist even after fever and other acute symptoms improve.

Bleeding Manifestations

Mild bleeding may occur, including:

• Gum bleeding
• Nosebleeds
• Easy bruising
• Petechiae
• Menstrual bleeding that is heavier than usual

More significant gastrointestinal or internal bleeding can occur in severe disease.

Warning Signs of Severe Disease

Warning signs require urgent clinical attention because they may indicate progression toward severe dengue.

Important warning signs include:

• Severe abdominal pain or abdominal tenderness
• Persistent vomiting
• Clinical evidence of fluid accumulation
• Mucosal bleeding
• Lethargy or restlessness
• Liver enlargement
• Progressive increase in hematocrit accompanied by a rapid fall in platelet count

Patients with warning signs should generally be evaluated more closely and may require hospitalization depending on their clinical condition and available monitoring.

Severe Dengue

Severe dengue is characterized by one or more major complications:

• Severe plasma leakage resulting in shock or respiratory distress
• Severe bleeding
• Severe organ involvement

Dengue shock occurs when plasma leakage becomes sufficiently extensive to compromise effective circulating blood volume.

Initially, compensatory mechanisms may maintain blood pressure. Tachycardia, peripheral vasoconstriction, cool extremities, and narrowing of pulse pressure may develop before overt hypotension.

As shock progresses, tissue perfusion becomes inadequate. The patient may develop altered mental status, oliguria, metabolic acidosis, and eventually multiorgan failure.

Severe organ involvement may include acute liver injury, encephalopathy, myocarditis, acute kidney injury, or other organ dysfunction.

Dengue Hemorrhagic Manifestations

Bleeding in dengue ranges from mild mucosal bleeding to life-threatening hemorrhage.

Thrombocytopenia is common, but the platelet count alone does not reliably predict whether severe bleeding will occur. Coagulopathy, vascular abnormalities, liver dysfunction, and systemic inflammation can all contribute.

Potential manifestations include:

• Petechiae
• Ecchymoses
• Gingival bleeding
• Epistaxis
• Gastrointestinal bleeding
• Hematuria
• Vaginal bleeding
• Intracranial bleeding in severe cases

Significant bleeding should prompt immediate assessment of hemodynamic status, hemoglobin, hematocrit, coagulation abnormalities, and possible sources of hemorrhage.

Diagnosis and Investigation

Diagnosis is based on the clinical presentation, epidemiological context, duration of illness, and laboratory testing.

Complete Blood Count

A complete blood count is one of the most useful routine investigations.

Common findings include:

• Leukopenia
• Thrombocytopenia
• Rising hematocrit during plasma leakage

The trend in laboratory values is often more informative than a single measurement.

A falling platelet count accompanied by a rising hematocrit can suggest evolving plasma leakage and should be interpreted in the context of the patient's clinical condition.

NS1 Antigen

The dengue NS1 antigen can be detected during the early phase of infection and is useful particularly during the first several days of illness.

A positive NS1 test can support the diagnosis of acute dengue, although the sensitivity of the test varies according to the assay, timing, and infection history.

RT-PCR

Reverse-transcription polymerase chain reaction can detect dengue viral RNA and is particularly useful during the early phase of infection.

It can also help identify the infecting serotype in appropriate laboratory settings.

Dengue IgM and IgG

Dengue-specific antibodies develop over the course of infection.

IgM generally becomes detectable after several days of illness and can support the diagnosis of recent infection.

IgG may indicate previous exposure or, depending on the clinical context and testing pattern, recent infection.

The interpretation of antibody testing can be complicated by cross-reactivity with other flaviviruses and by previous dengue infections.

Liver Function Tests

Liver enzymes may become elevated, particularly in patients with more significant disease.

Severe hepatic involvement can occur and may be associated with markedly elevated aminotransferases and impaired liver function.

Renal Function Tests

Serum creatinine, urea, electrolytes, and urine output should be monitored in patients with severe disease or significant dehydration and shock.

Coagulation Studies

Prothrombin time, activated partial thromboplastin time, fibrinogen, and other coagulation parameters may be evaluated in patients with significant bleeding or suspected coagulopathy.

Differential Diagnosis

Dengue can resemble many other acute febrile illnesses, especially during the early phase.

Important differential diagnoses include:

• Malaria
• Chikungunya
• Zika virus infection
• Typhoid fever
• Influenza
• COVID-19
• Leptospirosis
• Measles
• Viral hepatitis
• Meningococcal infection
• Other bacterial or viral infections

The differential diagnosis depends on geographic region, travel history, season, vaccination status, exposure history, and clinical findings.

In endemic regions, malaria should remain an important consideration in patients presenting with acute fever because missing malaria can have serious consequences.

Classification of Dengue

Clinically, dengue can be considered in categories such as dengue without warning signs, dengue with warning signs, and severe dengue.

This approach emphasizes the patient's current clinical status and the risk of deterioration rather than relying solely on older classifications based on dengue fever, dengue hemorrhagic fever, and dengue shock syndrome.

Dengue Without Warning Signs

Patients may have fever and typical symptoms but remain hemodynamically stable without evidence of significant plasma leakage, severe bleeding, or organ dysfunction.

Many such patients can be managed as outpatients if they can maintain oral intake, have reliable access to healthcare, and receive appropriate instructions about warning signs.

Dengue With Warning Signs

Patients with warning signs require closer observation and evaluation because they may deteriorate during the critical phase.

The decision to hospitalize depends on clinical status, comorbidities, pregnancy, age, ability to maintain oral intake, social circumstances, and availability of reliable follow-up.

Severe Dengue

Severe dengue requires urgent hospital-based management and may require intensive care.

The major problems are severe plasma leakage, shock, severe hemorrhage, and major organ dysfunction.

Treatment and Management

There is no routine specific antiviral treatment that reliably eliminates dengue virus. Management is primarily supportive and is aimed at maintaining adequate circulation, preventing dehydration, controlling symptoms, recognizing complications, and treating severe disease promptly.

The exact treatment depends on the patient's clinical phase and severity.

Fluid Management

Fluid therapy is one of the most important aspects of dengue management.

Patients with uncomplicated disease should generally receive adequate oral fluids if they can drink safely. Oral rehydration solutions, water, soups, and other appropriate fluids can help maintain hydration.

Intravenous fluids may be required when oral intake is inadequate, vomiting is persistent, dehydration is significant, or shock develops.

However, fluid therapy must be carefully individualized. Both inadequate and excessive fluid administration can be harmful.

In severe dengue, clinicians monitor:

• Blood pressure
• Pulse rate
• Pulse pressure
• Respiratory status
• Capillary refill
• Urine output
• Hematocrit
• Fluid balance
• Evidence of pulmonary edema or other fluid overload

During the recovery phase, previously leaked fluid can return to the circulation. Continuing aggressive intravenous fluid therapy after plasma leakage has resolved may therefore cause fluid overload and respiratory compromise.

Antipyretic Treatment

Paracetamol (acetaminophen) is generally preferred for fever and pain when appropriate.

Non-steroidal anti-inflammatory drugs such as ibuprofen, aspirin, and other drugs that can increase bleeding risk are generally avoided when dengue is suspected, particularly because thrombocytopenia and bleeding complications may occur.

Patients should also avoid unnecessary medications that could worsen bleeding or affect the liver.

Monitoring During Illness

Clinical monitoring is essential because dengue can change rapidly.

Important parameters include:

• Temperature
• Heart rate
• Blood pressure
• Respiratory rate
• Oxygen saturation when indicated
• Capillary refill
• Mental status
• Urine output
• Oral intake
• Vomiting
• Bleeding
• Abdominal pain
• Hematocrit and platelet trends

A patient who appears stable during the febrile phase may require more intensive observation as the fever resolves.

Management of Dengue Shock

Dengue shock is a medical emergency.

The primary goal is restoration of adequate tissue perfusion while avoiding fluid overload.

Initial management generally involves carefully administered isotonic crystalloid solutions with frequent reassessment.

The patient's clinical response, hematocrit, urine output, blood pressure, pulse pressure, peripheral perfusion, and respiratory status help guide further treatment.

If shock persists despite appropriate fluid resuscitation, clinicians must reconsider the underlying cause and assess for severe plasma leakage, significant hemorrhage, myocardial dysfunction, or other complications.

Patients with severe shock may require intensive-care management and invasive monitoring depending on the circumstances.

Management of Bleeding

Minor bleeding does not automatically require blood transfusion.

Patients with clinically significant bleeding should undergo rapid assessment of circulation and the severity and source of hemorrhage.

If major blood loss is present, appropriate blood products may be required.

Routine prophylactic platelet transfusion solely because the platelet count is low is generally not recommended in the absence of clinically significant bleeding or another specific indication.

The patient's overall clinical condition should guide transfusion decisions rather than platelet count alone.

Management of Organ Dysfunction

Severe dengue can affect multiple organs and requires multidisciplinary supportive care.

Liver Involvement

Patients with significant hepatic involvement require careful monitoring of liver enzymes, glucose, coagulation, and other indicators of hepatic function.

Potentially hepatotoxic medications should be avoided or used cautiously.

Kidney Involvement

Renal function should be monitored through serum creatinine, electrolytes, urine output, and fluid balance.

Acute kidney injury may result from shock, dehydration, inflammation, or other mechanisms.

Neurological Complications

Neurological manifestations can include altered consciousness, seizures, encephalopathy, encephalitis-like presentations, and other abnormalities.

Such findings require evaluation for severe dengue as well as alternative diagnoses.

Cardiac Complications

Myocarditis and cardiac dysfunction are uncommon but potentially serious complications.

Patients with unexplained hypotension, arrhythmias, chest symptoms, or signs of cardiac dysfunction may require ECG, cardiac biomarkers, echocardiography, and appropriate specialist assessment.

Indications for Hospitalization

Hospitalization should be considered when patients have warning signs or severe dengue.

It may also be appropriate when the patient:

• Cannot maintain adequate oral hydration
• Has persistent vomiting
• Has significant bleeding
• Has severe abdominal pain
• Has altered consciousness
• Has significant comorbid disease
• Is pregnant
• Is very young or elderly
• Has poor access to reliable follow-up
• Lives in circumstances where safe outpatient monitoring is difficult

The decision should always be individualized.

Complications

Although most dengue infections resolve, severe complications can occur.

Important complications include:

• Dengue shock syndrome
• Severe bleeding
• Plasma leakage
• Pleural effusion
• Ascites
• Acute liver injury
• Acute kidney injury
• Encephalopathy
• Encephalitis
• Myocarditis
• Cardiac dysfunction
• Respiratory distress
• Metabolic disturbances
• Multiorgan failure

The risk of complications is greatest during the critical phase, particularly when warning signs are present.

Dengue in Children

Children may present differently from adults. They can initially appear relatively well and then deteriorate rapidly.

Parents and caregivers should be educated about warning signs such as persistent vomiting, severe abdominal pain, unusual sleepiness, restlessness, bleeding, difficulty breathing, reduced urine output, and inability to drink.

Children with suspected dengue require careful assessment of hydration and circulation because fluid management can be particularly challenging.

Dengue During Pregnancy

Dengue during pregnancy requires careful monitoring because both the pregnant patient and fetus may be affected.

Pregnancy can complicate assessment of fluid status and may increase the consequences of bleeding and hemodynamic instability.

Potential maternal complications include severe bleeding, shock, and organ dysfunction. Vertical transmission around the time of delivery has also been reported.

Pregnant patients with suspected dengue should therefore receive appropriate medical evaluation and close monitoring when clinically indicated.

Prevention of Dengue

Because dengue is primarily mosquito-borne, prevention focuses heavily on reducing mosquito exposure and eliminating breeding sites.

Individuals can reduce exposure by:

• Using mosquito repellents appropriately
• Wearing long sleeves and long trousers
• Using window and door screens
• Sleeping under mosquito nets when appropriate
• Keeping water-storage containers covered
• Removing stagnant water
• Emptying containers that collect rainwater
• Disposing of discarded tires and other water-holding waste
• Maintaining clean surroundings

Community-level mosquito control is equally important.

Vector-control programs may involve environmental management, larval control, surveillance, and targeted insect-control measures.

Environmental Control

The most effective long-term strategy is to reduce mosquito breeding sites.

Water containers should be emptied, cleaned, covered, or otherwise managed so mosquitoes cannot lay eggs.

Special attention should be given to small containers that are often overlooked.

Community participation is essential because mosquitoes can breed around homes, schools, workplaces, markets, and public areas.

Personal Protection

Because Aedes mosquitoes commonly bite during the daytime as well as at other times, protection should not be limited to nighttime.

Appropriate mosquito repellents can reduce the risk of bites. Clothing that covers the arms and legs can provide additional protection.

Homes should be designed and maintained to reduce mosquito entry where feasible.

Vaccination

Dengue vaccines have been developed, but vaccination policies vary by country and vaccine because recommendations depend on age, previous dengue infection, epidemiological circumstances, and the specific vaccine available.

Vaccination should therefore follow current national or regional public-health guidance rather than a one-size-fits-all approach.

Vaccination does not replace mosquito-control measures.

Public Health Importance

Dengue prevention requires coordinated action between individuals, communities, healthcare professionals, laboratories, and public-health authorities.

Early recognition of outbreaks allows health systems to prepare for increased patient loads and ensure adequate supplies, diagnostic capacity, trained personnel, and hospital beds.

Public education is particularly important because early symptoms can resemble other common infections. People living in endemic areas should know the warning signs and understand why clinical reassessment may be necessary when fever begins to subside.

Prognosis

The prognosis of dengue varies according to the severity of illness and the timeliness of appropriate care.

Most uncomplicated cases recover with supportive treatment and adequate hydration. Fatigue and weakness can persist after the acute illness has resolved.

Severe dengue has a substantially greater risk of complications and death, particularly when shock, severe bleeding, or major organ dysfunction develops.

Early recognition of warning signs and appropriate fluid management are among the most important factors in preventing progression to life-threatening disease.

Key Clinical Points

Dengue fever should be approached as a dynamic illness rather than a static febrile condition. The patient's clinical status can change rapidly, particularly around the time the fever resolves.

The most important clinical principles include recognizing the characteristic symptoms, considering dengue in appropriate epidemiological settings, using laboratory investigations appropriately, monitoring hematocrit and platelet trends, identifying warning signs, maintaining adequate hydration, avoiding medications that increase bleeding risk, and recognizing severe dengue early.

A falling platelet count by itself does not necessarily mean that severe dengue is developing. Conversely, a patient can become critically ill because of plasma leakage and shock even before the platelet count reaches its lowest point.

The critical phase deserves particular attention because patients may deteriorate shortly after appearing to improve. Careful monitoring during this period can allow clinicians to identify plasma leakage, shock, bleeding, or organ dysfunction before irreversible complications occur.

Patient Education

Patients with suspected or confirmed dengue should receive clear instructions about hydration, medication use, follow-up, mosquito protection, and warning signs.

They should seek urgent medical care if they develop severe abdominal pain, persistent vomiting, bleeding, difficulty breathing, extreme weakness, confusion, marked restlessness, reduced urine output, cold or clammy extremities, or other signs of deterioration.

Patients should also understand that fever improvement does not necessarily mean that the danger has completely passed. The period around defervescence may be the time when severe disease begins.

Family members can help by monitoring fluid intake, urine output, general behavior, bleeding, and other warning signs.

Conclusion

Dengue fever is a major mosquito-borne viral disease with a wide clinical spectrum ranging from uncomplicated febrile illness to severe disease characterized by plasma leakage, shock, bleeding, and organ dysfunction. Its management depends heavily on understanding the clinical phases and recognizing that the period around defervescence can be particularly dangerous.

Early diagnosis, careful monitoring, appropriate fluid management, avoidance of harmful medications, recognition of warning signs, and timely referral of severe cases are central to reducing complications and mortality. Prevention remains equally important and depends on mosquito-control measures, elimination of breeding sites, personal protection, community participation, and appropriate use of available vaccination strategies.